Mark Koban says Trump’s health care “can provide hundreds of billions” – NYSE: NVO), Pfizer (NYSE: PFE)

Billionaire Mark Kobe He expressed his support for the president Donald TrumpExecutive healthcare order in 2025, while emphasizing its ability to fix the role of pharmacy allocations (PBMS) in the American health care system.

What happenedIn a post on X, directed to President Trump on Wednesday, the Cuban chanted the women that aims to fix PBMS, entities that control 80 % of American recipes. He emphasized the potential of the matter to save billions and improve the patient’s wellness.

Cuban proposals include separating the formula from PBMS to focus on wellness, imposing transparency in claims of claims to improve the patient’s results, and eliminate specialized drug levels that inflame costs. He also urged action on issues such as the dual 340B program, which is estimated at the cost of 2023 at the cost of hospitals of $ 500 million every year.

“Make them for wellness, don’t pay for playing like a grocery store. This discounts ends and allows clear prices. It also allows better care and well -being,” said Shark Tank CeleBrist.

Cuban, founder The cost company in addition to the pharmaceutical companyI also criticized PBM tactics such as biomedical replacement calls, as doctors lead to prescribing the basis for higher margins, which is the practice of enabling vertical integration. He pointed to FTC’s interests in the nineties when pharmaceutical companies captured PBMS, which led to an open formulation.

See too: China rejects the “TROMP game”, the World Trade Organization files complaint: The talks can only continue based on “mutual respect”

Why do it matterTrump’s executive order comes as part of a wider effort to reduce medicine prices and reduce medical care costs. The administration is scheduled to negotiate the prices of the second batch of 15 drugs, including Novo Nordsk‘s NVO Breasty diabetes and drugs that lose weight Oclisit and Fujiofi, along with Vizar‘s PFE IBRANCE and XTANDI cancer treatments

In addition, the Trump administration revealed “major tariff” plans on foreign pharmaceutical products. This step can affect the pharmaceutical industry, as the US Department of Commerce launched an investigation into the potential national security risks offered by the country’s dependence on imported drugs and major drug components.

Meanwhile, the Cubans, an explicit critic of the Trump administration, have always paid health care at reasonable and global prices. He has consistently referred to the shortcomings in the American health care system, which increases its complexity by large insurance companies and pharmacy directors managers.

Photo via Shutterstock

Disintegration: This content was partially produced with the help of artificial intelligence tools and was reviewed and published by Beenzinga editors.